Feb 24 (Reuters) - Hims & Hers (HIMS.N), opens new tab said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo Nordisk (NOVOb.CO), opens new ...

European markets are expected to open in mixed territory Thursday, stumbling lower as President Donald Trump’s tariffs policy upends global trading relations.

European shares were mostly lower on Thursday, after the White House threatened to place a 2005 tariff on EU wine, champagne and spirits in response to the bloc's own retaliatory measures.

By Nikhil Sharma (Reuters) -European shares edged up on Thursday, supported by a rise in healthcare stocks, though investor ...

HOLLYWOOD’S award season is in full swing – and it’s abundantly clear the super-skinny celebrity look is back with a ...

European markets are heading for a sharply higher open amid hopes that a ceasefire can be reached to pause the war in Ukraine ...

European markets are heading for a sharply higher open amid hopes that a ceasefire can be reached to pause the war in Ukraine.

An investigation by Channel 4 Dispatches has uncovered teenagers can purchase the weight-loss drug Wegovy from high street ...

Rosenthal: Compared to semiconductors— Gilbert: Or Novo Nordisk [a Danish pharmaceutical company ... How does the watch industry differ from leather goods, fashion, and jewelry? Rosenthal: Most ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford ...

Novo Nordisk (NVO) is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical companies next week. CEO Lars Jørgensen told reporters Thursday ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive ...